EZETIMIBE
- Product NDC
- 71335-3092
- 11-digit product format
- 713353092
- Labeler code
- 71335
- Product ID
- 71335-3092_1329fd6e-ab21-40be-8584-6886362ab4b6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- EZETIMIBE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA210859
- Marketing category
- ANDA
- Marketing start
- 2022-07-26
- Substance
- EZETIMIBE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- EZETIMIBE
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| EZETIMIBE | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | EOR26LQQ24 |
| Rxcui | 349556 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71335-3092-1 | 71335309201 | 30 TABLET in 1 BOTTLE (71335-3092-1) | 30 tablet | 2026-02-17 | No | No | Current |
| 71335-3092-2 | 71335309202 | 90 TABLET in 1 BOTTLE (71335-3092-2) | 90 tablet | 2026-02-17 | No | No | Current |
| 71335-3092-3 | 71335309203 | 28 TABLET in 1 BOTTLE (71335-3092-3) | 28 tablet | 2026-02-17 | No | No | Current |
| 71335-3092-4 | 71335309204 | 18 TABLET in 1 BOTTLE (71335-3092-4) | 18 tablet | 2026-02-17 | No | No | Current |
| 71335-3092-5 | 71335309205 | 60 TABLET in 1 BOTTLE (71335-3092-5) | 60 tablet | 2026-02-17 | No | No | Current |